AmiLyfe Bioscience

At Amilyfe, we are dedicated to tackling one of the most pressing health issues facing millions of children today—environmental enteropathy. This condition, which affects over 444 million children globally, leads to stunting and wasting due to malabsorption, not a lack of food. Our revolutionary formulation, recently validated in a Lancet-published study, has proven to reduce the duration of diarrhea and improve nutrient absorption. This breakthrough has the potential to transform patient care and address a critical global health challenge. We believe in a future where every child has the opportunity to thrive. Join us in raising awareness and driving change. #GlobalHealth #ChildNutrition #HealthcareInnovation #ORSMarket #Amilyfe

We are thrilled to announce that AmiLyfe BioScience has acquired the assets of Entrinsic Bioscience, a strategic move that significantly enhances our capabilities and broadens our product portfolio. This acquisition includes rights to over 180 patents and trademarks, the renowned enterade® brand, and all existing licenses and product lines, establishing a robust technology platform fueled by our expertise in biomapping and electrophysiology. Key Highlights: Advanced Technology: With the integration of Entrinsic Bioscience’s assets, we now possess a powerful arsenal of IP and product lines, enhancing our innovative capabilities. Maestro™ AI Platform: Our proprietary AI platform, Maestro™, accelerates research into the cellular dynamics of natural amino acids, revealing their impact on crucial physiological functions. Expanded Product Line: We’ve identified over 50 biofunctional formulations targeting gut health, hydration, respiratory disease, and skincare, all clinically proven to provide significant health benefits. Innovative Solutions: Our flagship product, enterade oncology®, is a pioneering medical food that reduces the side effects of chemotherapy, radiation, and immunotherapy, benefiting patients in over 700 cancer centers worldwide. "AmiLyfe is here to revolutionize healthcare by blending biology and nature to elevate wellness from within." - Stephen Gatto, Chairman and CEO From protecting astronauts from GI effects during space travel to combating severe dehydration in infants and optimizing sports performance, our journey over the past 15 years has been marked by groundbreaking research and development. This acquisition propels us further in our mission to create scientifically validated, IP-protected products that improve the quality of life for individuals worldwide. Join us as we embark on this exciting new chapter, advancing health and wellness through the transformative power of natural amino acids! #HealthcareInnovation #AmiLyfeBioscience #Bioscience #HealthAndWellness #Sustainability #Innovation